HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yunqing Qiu Selected Research

xylopyranose

3/2020Potential Cytotoxicity, Pharmacokinetics, and Excretion Properties of Sapindoside B from the Seeds of Nigella sativa var. hispidula.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yunqing Qiu Research Topics

Disease

19Neoplasms (Cancer)
01/2022 - 12/2010
19COVID-19
01/2022 - 01/2020
8Hepatocellular Carcinoma (Hepatoma)
04/2022 - 12/2010
7Infections
01/2022 - 03/2016
4Hypoxia (Hypoxemia)
12/2021 - 11/2018
4Critical Illness (Critically Ill)
06/2020 - 01/2020
3Sepsis (Septicemia)
12/2021 - 11/2020
3Cytokine Release Syndrome
01/2021 - 01/2020
2Liver Cirrhosis (Hepatic Cirrhosis)
04/2022 - 04/2020
2Hand-Foot Syndrome
01/2022 - 10/2018
2Inflammation (Inflammations)
01/2022 - 01/2021
2Fever (Fevers)
01/2022 - 01/2020
2Hepatitis
01/2022 - 04/2020
2Pneumonia (Pneumonitis)
05/2020 - 01/2013
2Neoplasm Metastasis (Metastasis)
01/2020 - 01/2020
1Chronic Hepatitis C
04/2022
1Communicable Diseases (Infectious Diseases)
01/2022
1Virus Diseases (Viral Diseases)
11/2021
1Gestational Diabetes (Gestational Diabetes Mellitus)
06/2021
1Convalescence
01/2021
1Human Influenza (Influenza)
01/2021
1Cross Infection (Nosocomial Infection)
12/2020
1Drug-Related Side Effects and Adverse Reactions
05/2020
1Chronic Hepatitis B
04/2020

Drug/Important Bio-Agent (IBA)

6MicroRNAs (MicroRNA)IBA
04/2022 - 01/2013
6Pharmaceutical PreparationsIBA
02/2021 - 03/2016
5Biomarkers (Surrogate Marker)IBA
04/2022 - 01/2013
5Antiviral Agents (Antivirals)IBA
02/2021 - 01/2020
4Oxygen (Dioxygen)IBA
12/2021 - 11/2018
4Carbapenems (Carbapenem Antibiotics)IBA
12/2021 - 01/2018
4LopinavirFDA Link
02/2021 - 01/2020
4CytokinesIBA
01/2021 - 01/2020
3RNA (Ribonucleic Acid)IBA
01/2022 - 01/2020
3Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2020
3Viral RNAIBA
01/2022 - 01/2020
3Liposomes (Liposome)IBA
12/2021 - 11/2018
3Ritonavir (Norvir)FDA Link
01/2021 - 01/2020
3Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
01/2021 - 03/2016
3Hemoglobins (Hemoglobin)IBA
01/2019 - 01/2014
2Capecitabine (Xeloda)FDA Link
01/2022 - 10/2018
2VaccinesIBA
01/2022 - 01/2017
2Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2021
2Immune Checkpoint InhibitorsIBA
01/2022 - 01/2020
2Therapeutic UsesIBA
01/2022 - 12/2021
2ceftazidime drug combination avibactamIBA
12/2021 - 01/2021
2Anti-Bacterial Agents (Antibiotics)IBA
06/2021 - 12/2020
2AcidsIBA
02/2021 - 01/2020
2Interleukin-10 (Interleukin 10)IBA
01/2021 - 01/2021
2umifenovirIBA
01/2021 - 01/2020
2Phosphotransferases (Kinase)IBA
05/2020 - 05/2017
2Peptides (Polypeptides)IBA
01/2019 - 11/2015
2Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2019 - 11/2018
1cobicistat mixture with darunavirIBA
01/2022
1Neoplasm Antigens (Tumor Antigens)IBA
01/2022
1Interleukin-8 (Interleukin 8)IBA
01/2022
1LigandsIBA
01/2022
1InterleukinsIBA
01/2022
1p38 Mitogen-Activated Protein KinasesIBA
01/2022
1perflubron (L 1913)FDA Link
12/2021
1Colistin (Coly-Mycin)FDA Link
12/2021
1AntibodiesIBA
11/2021
1Neutralizing AntibodiesIBA
11/2021
1Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric
06/2021
1LipidsIBA
06/2021
1TMC-310911IBA
02/2021
1Peptide Hydrolases (Proteases)FDA Link
02/2021
1poly(tetramethylene succinate-co-tetramethylene adipate)IBA
02/2021
1lopinavir-ritonavir drug combination (Kaletra)FDA Link
02/2021
1danoprevirIBA
02/2021
1Darunavir (Prezista)FDA Link
02/2021
1baloxavirIBA
02/2021
1Protease Inhibitors (Protease Inhibitor)IBA
02/2021
1favipiravirIBA
02/2021
1AztreonamFDA LinkGeneric
01/2021
1Interleukin-18 (Interleukin 18)IBA
01/2021
1avibactamIBA
01/2021
1Nucleic AcidsIBA
01/2021
1MethylprednisoloneFDA LinkGeneric
01/2021
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2021
1Interleukin-4 (Interleukin 4)IBA
01/2021
1Interferon Type IIBA
01/2021
1Amino AcidsFDA Link
01/2021
1ChemokinesIBA
01/2021
1Macrophage Colony-Stimulating FactorIBA
01/2021
1FurinIBA
12/2020
1Indicators and Reagents (Reagents)IBA
11/2020
1Cyclin D1IBA
10/2020
1Adrenal Cortex Hormones (Corticosteroids)IBA
05/2020
1Sorafenib (BAY 43-9006)FDA Link
05/2020
1Phosphatidylinositols (Phosphatidylinositol)IBA
05/2020
1Radioisotopes (Radionuclides)IBA
04/2020
1Cisplatin (Platino)FDA LinkGeneric
03/2020

Therapy/Procedure

6Therapeutics
01/2022 - 03/2016
3Artificial Liver (Bioartificial Liver)
06/2020 - 01/2020
2Immunotherapy
01/2022 - 01/2020
2Photothermal Therapy
01/2019 - 11/2015
2Lasers (Laser)
11/2018 - 11/2015
1Plasma Exchange
06/2020
1Medication Errors (Medication Error)
05/2020
1Duration of Therapy
05/2020